ABOUT ALMAC CLINICAL TECHNOLOGIES
Almac Clinical Technologies is a trusted partner providing industry-leading clinical trial technology, expertise, and seamless service at every stage of the participant journey. Supporting biopharmaceutical sponsors and CROs in accelerating drug development through its industry-leading Interactive Response Technology (IRT) and integrated electronic Clinical Outcome Assessment (eCOA) platform.
With a steadfast commitment to quality, Almac embeds compliance, precision, and reliability into every phase of the clinical trial process. Its solutions streamline site, patient, and supply management while delivering real-time data and intuitive tools that enable informed, data-driven decisions and enhance global participant engagement.
FEATURED ARTICLES
-
![GettyImages-1316574146-computer-monitoring-office-hands-keyboard]( "Master Protocols: Implementing Effective Treatment Adaptations")
From balancing treatment ratios and managing eligibility to accommodating site-specific readiness and protocol amendments, a well-designed IRT system enables seamless transitions with minimal disruption.
-
![IRT Getty 1407865352]( "Unique IRT Implementation Considerations For Personalized Medicine Trials")
The rise of personalized and precision medicine is reshaping the clinical trial landscape and, as the number of these specialized trials increases, so does the complexity of managing them effectively.
-
![GettyImages-2095813668-meeting-sustainability-screen-learning]( "Improving Site Efficiency With Automated Drug Resupply And Forecasting")
Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
![GettyImages-525755915 clinical team eCOA]( "The Strategic Advantage Of eCOA And IRT")
The future lies in unified, interoperable eCOA–IRT solutions that streamline operations, improve data integrity, and enhance patient and site experience.
-
![laboratory scientist laptop GettyImages-1302454417]( "Future Predictions For Clinical Technologies")
In 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.
CONTACT INFORMATION
Almac Clinical Technologies
20 Seagoe Industrial Estate
Craigavon, BT63 5QD
UNITED KINGDOM
FEATURED SOLUTIONS
-
![Almac IRT expo]( "Almac Clinical Leader Solutions Expo September 2025 - IRT")
Complexity is no longer the exception in high stakes clinical trials, it has become the rule.
-
![Clinical Leader Solutions Expo]( "Clinical Leader Smart Sourcing Solutions Expo: Retention By Design")
Enhance participant retention through intuitive UX and real-time site support tools, while seamlessly integrating with IRT, EDC, and third-party platforms.
-
![Woman taking medications-GettyImages-1782441970]( "Decentralized Trials Support: Direct-To-Patient Supply Management")
Direct-to-patient shipments are reshaping decentralized trials by placing patient convenience at the center of study design.
-
![Almac Visit Management]( "Site And Participant-Friendly Visit Scheduling Built For Global Trials")
This scalable, participant-centric solution strengthens site efficiency and supports sponsors in executing complex clinical studies with confidence.
-
![GettyImages-2183708450-doctor-with-patient-tablet-doctors-office]( "eCOA: Participant-Focused Electronic Assessment Capture Built For Global Trials")
High-quality outcome data is essential to clinical trial success, and this eCOA solution provides participant-first design features while supporting multiple modalities.
